KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Assets: 2010-2025

Historic Return on Assets for Emergent BioSolutions (EBS) over the last 13 years, with Sep 2025 value amounting to 0.05%.

  • Emergent BioSolutions' Return on Assets rose 19.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 19.00%. This contributed to the annual value of -0.12% for FY2024, which is 19.00% up from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Return on Assets is 0.05%, which was down 46.25% from 0.10% recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Return on Assets high stood at 0.13% for Q1 2021, and its period low was -0.41% during Q4 2023.
  • Its 3-year average for Return on Assets is -0.19%, with a median of -0.14% in 2024.
  • In the last 5 years, Emergent BioSolutions' Return on Assets slumped by 39bps in 2023 and then spiked by 45bps in 2025.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Return on Assets stood at 0.08% in 2021, then declined by 15bps to -0.07% in 2022, then crashed by 34bps to -0.41% in 2023, then grew by 28bps to -0.13% in 2024, then grew by 19bps to 0.05% in 2025.
  • Its Return on Assets stands at 0.05% for Q3 2025, versus 0.10% for Q2 2025 and -0.09% for Q1 2025.